Free Trial

UnitedHealth Group Incorporated $UNH Shares Sold by Logan Capital Management Inc.

UnitedHealth Group logo with Medical background

Key Points

  • Logan Capital Management Inc. has reduced its holdings in UnitedHealth Group by 8.4%, selling 1,781 shares during the 1st quarter, leaving it with a total of 19,397 shares valued at approximately $10.16 million.
  • Institutional investors own 87.86% of UnitedHealth Group's stock, with several large investors, like Bayforest Capital, significantly increasing their positions during the same period.
  • Analyst ratings have varied, with Wells Fargo lowering its price target from $306 to $267 while the average target price across analysts is currently $354.86, indicating a generally positive outlook despite some recent downgrades.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Logan Capital Management Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,397 shares of the healthcare conglomerate's stock after selling 1,781 shares during the quarter. Logan Capital Management Inc.'s holdings in UnitedHealth Group were worth $10,159,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $42,000. Finally, O Brien Wealth Partners LLC increased its position in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wells Fargo & Company lowered their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. HSBC reiterated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $354.86.

Get Our Latest Report on UNH

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $320.46 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $290.24 billion, a price-to-earnings ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.45. The stock's fifty day simple moving average is $288.96 and its 200-day simple moving average is $371.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 EPS. The business's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines